Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Another vaccine, from Novavax, was 89% effective in a U.K. trial, but both were less potent against the South African coronavirus mutation.
A slow vaccine rollout and the emergence of new coronavirus mutations threaten progress in reducing new cases and death.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
A machine learning algorithm designed small sets of proteins that boasted the greatest potential to elicit a broad-based immune response.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
The Janssen Therapeutics funding aims to help African Americans living with HIV in the South and in rural areas.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.